These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2086161)

  • 1. Inhibition of tyrosine kinase and epidermal growth factor receptor internalization by lavendustin A methyl ester in cultured A431 cells.
    Onoda T; Isshiki K; Takeuchi T; Tatsuta K; Umezawa K
    Drugs Exp Clin Res; 1990; 16(6):249-53. PubMed ID: 2086161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ inhibition of tyrosine protein kinase by erbstatin.
    Imoto M; Umezawa K; Sawa T; Takeuchi T; Umezawa H
    Biochem Int; 1987 Nov; 15(5):989-95. PubMed ID: 3501720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus.
    Onoda T; Iinuma H; Sasaki Y; Hamada M; Isshiki K; Naganawa H; Takeuchi T; Tatsuta K; Umezawa K
    J Nat Prod; 1989; 52(6):1252-7. PubMed ID: 2614420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor.
    Huang YT; Hwang JJ; Lee PP; Ke FC; Huang JH; Huang CJ; Kandaswami C; Middleton E; Lee MT
    Br J Pharmacol; 1999 Nov; 128(5):999-1010. PubMed ID: 10556937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by two lavendustins of the tyrosine kinase activity of pp60F527 in vitro and in intact cells.
    Agbotounou WK; Umezawa K; Jacquemin-Sablon A; Pierre J
    Eur J Pharmacol; 1994 Sep; 269(1):1-8. PubMed ID: 7828651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid cells following psoralen/ultraviolet light treatment.
    Mermelstein FH; Abidi TF; Laskin JD
    Mol Pharmacol; 1989 Dec; 36(6):848-55. PubMed ID: 2557535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitors of oncogene product functions].
    Umezawa K
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):315-21. PubMed ID: 2155583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
    Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic analysis of the inhibition of the epidermal growth factor receptor tyrosine kinase by Lavendustin-A and its analogue.
    Hsu CY; Persons PE; Spada AP; Bednar RA; Levitzki A; Zilberstein A
    J Biol Chem; 1991 Nov; 266(31):21105-12. PubMed ID: 1939153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the epidermal growth factor receptor by growth-modulating agents: effects of staurosporine, a protein kinase inhibitor.
    Friedman B; Fujiki H; Rosner MR
    Cancer Res; 1990 Feb; 50(3):533-8. PubMed ID: 1688732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tyrphostin on cell growth and tyrosine kinase activity of epidermal growth factor receptor in human gliomas.
    Miyaji K; Tani E; Shindo H; Nakano A; Tokunaga T
    J Neurosurg; 1994 Sep; 81(3):411-9. PubMed ID: 8057149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of epidermal growth factor-induced DNA synthesis by tyrosine kinase inhibitors.
    Umezawa K; Hori T; Tajima H; Imoto M; Isshiki K; Takeuchi T
    FEBS Lett; 1990 Jan; 260(2):198-200. PubMed ID: 2298299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
    Brunton VG; Carlin S; Workman P
    Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoskeletal and morphological changes associated with the specific suppression of the epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid carcinoma.
    Nelson JM; Fry DW
    Exp Cell Res; 1997 Jun; 233(2):383-90. PubMed ID: 9194500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine kinase inhibitors. 13. Structure-activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]pyrido[4,3-d]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.
    Thompson AM; Murray DK; Elliott WL; Fry DW; Nelson JA; Showalter HD; Roberts BJ; Vincent PW; Denny WA
    J Med Chem; 1997 Nov; 40(24):3915-25. PubMed ID: 9397172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloride efflux during the progesterone-initiated human sperm acrosome reaction is inhibited by lavendustin A, a tyrosine kinase inhibitor.
    Meizel S; Turner KO
    J Androl; 1996; 17(4):327-30. PubMed ID: 8889693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of a series of lavendustin A analogues that inhibit EGFR and Syk tyrosine kinases, as well as tubulin polymerization.
    Mu F; Coffing SL; Riese DJ; Geahlen RL; Verdier-Pinard P; Hamel TE; Johnson J; Cushman M
    J Med Chem; 2001 Feb; 44(3):441-52. PubMed ID: 11462983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.
    Reddy KB; Mangold GL; Tandon AK; Yoneda T; Mundy GR; Zilberstein A; Osborne CK
    Cancer Res; 1992 Jul; 52(13):3636-41. PubMed ID: 1617636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity.
    Gulli LF; Palmer KC; Chen YQ; Reddy KB
    Cell Growth Differ; 1996 Feb; 7(2):173-8. PubMed ID: 8822200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antiproliferative agents derived from lavendustin A.
    Nussbaumer P; Winiski AP; Cammisuli S; Hiestand P; Weckbecker G; Stütz A
    J Med Chem; 1994 Nov; 37(24):4079-84. PubMed ID: 7990108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.